title: Heterogeneity of the anti-Ro(SSA) response in rheumatic diseases.
abstract: OBJECTIVE
  The immune response to the Ro(SSA) antigen is heterogeneous. Anti-Ro(SSA) positive sera may contain antibodies recognizing either a 60 or a 52 kDa polypeptide component of the Ro(SSA) particle. Thus we sought to determine the profile of anti-Ro(SSA) antibodies defined by immunoblotting in patients with rheumatic diseases.
  
  
  METHODS
  Immunoblotting against human placenta extract and ELISA against recombinant Ro(SSA) antigen as confirmatory tests were done to detect anti-Ro(SSA) antibodies in 563 sera from patients with systemic lupus erythematosus (SLE). Sjögren's syndrome (SS), rheumatoid arthritis (RA) and other connective tissue diseases.
  
  
  RESULTS
  Anti-52 kDa antibodies were more common in primary patients with SS (9/22; 40.9%) than in patients with SLE (29/135; 21.4%) or patients with RA (7/315; 2.2%). Anti-60 kDa antibodies were more frequent in patients with SLE (26/135; 19.2%) than in patients with primary SS (2/22; 9%) or RA (17/315; 5.3%). None of the 22 patients with primary SS had only antibodies to the 60 kDa polypeptide. Among the 153 patients whose sera were positive by ELISA, 73 (47.7%) were negative by immunoblotting. The most frequent diagnoses in these sera were RA and SLE. The anti-52 kDa sera had higher optical density values compared to anti-60 kDa sera.
  
  
  CONCLUSIONS
  Our observations indicate the existence of qualitatively and quantitatively different anti-Ro(SSA) responses in the rheumatic diseases. The major responses are anti-52 kDa antibodies in primary SS, both anti-52 and anti-60 kDa antibodies in SLE, and anti-60 kDa antibodies in RA and other connective tissue diseases.
authors.affiliation: Servicio de Reumatología, Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain.
authors.forename: F J
authors.initials: FJ
authors.lastname: López-Longo
authors.forename: M
authors.initials: M
authors.lastname: Rodríguez-Mahou
authors.forename: M
authors.initials: M
authors.lastname: Escalona
authors.forename: T
authors.initials: T
authors.lastname: Pérez
authors.forename: I
authors.initials: I
authors.lastname: Monteagudo
authors.forename: A
authors.initials: A
authors.lastname: Sánchez-Atrio
authors.forename: R
authors.initials: R
authors.lastname: Grau
authors.forename: C
authors.initials: C
authors.lastname: González
authors.forename: A C
authors.initials: AC
authors.lastname: Moreno
authors.forename: L
authors.initials: L
authors.lastname: Carreño
mesh_terms: D000974:Antibodies, Antinuclear / Q000097:blood* / Q000276:immunology; D016022:Case-Control Studies; D003240:Connective Tissue Diseases / Q000276:immunology; D004591:Electrophoresis, Polyacrylamide Gel; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D015151:Immunoblotting; D012216:Rheumatic Diseases / Q000276:immunology*
chemical_list: D000974:Antibodies, Antinuclear; C035356:SS-A antibodies